OraSure Technologies Inc.

(OSUR) Trade

By |

Profile

OraSure Technologies Inc is engaged in the development, manufacturing, and distribution of oral fluid diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. Its reportable segments are OSUR and DNAG. The OSUR business, consists of the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices, DNAG segment manufacture and sell kits that are used to collect, stabilize, transport and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome and animal genetics markets. It generates a majority of its revenue from the OSUR business segment.

Contact Information

Website: www.orasure.com
Email: investorinfo@orasure.com
Main Phone: +1 610 882-1820
Address: 220 East First Street
Address 2: Suite 300
State: PA
City / Town: Bethlehem
Country: USA
Postal Code: 18015

Issuer Information

Exchange: NGS
CEO: Stephen S. Tang
Employees: 398
NAICS: Surgical and Medical Instrument Manufacturing(339112)

Equities News

View More


Gathering Data... Please wait

Profile

OraSure Technologies Inc is engaged in the development, manufacturing, and distribution of oral fluid diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. Its reportable segments are OSUR and DNAG. The OSUR business, consists of the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices, DNAG segment manufacture and sell kits that are used to collect, stabilize, transport and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome and animal genetics markets. It generates a majority of its revenue from the OSUR business segment.

Contact Information

Website: www.orasure.com
Email: investorinfo@orasure.com
Main Phone: +1 610 882-1820
Address: 220 East First Street
Address 2: Suite 300
State: PA
City / Town: Bethlehem
Country: USA
Postal Code: 18015

Issuer Information

Exchange: NGS
CEO: Stephen S. Tang
Employees: 398
NAICS: Surgical and Medical Instrument Manufacturing(339112)

Equities News

View More
$ 7.71 $ 0.24 (3.21%)
Last Price 7.71 Change $ 0.24 Change % 3.21 Tick N/A
Bid 6.00 Bid Size 300.00 Ask 7.81 Ask Size 100.00
Open 7.60 High 7.81 Low 7.60 Prev Close 7.47
Last Trade Volume 749,427 52 Wk Hi 15.11 52 Wk Low 6.35
Market Cap 475.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 61,724,870.00 EPS (TTM) 0.32 PE Ratio 22.50 Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 15 81
Number of Buys 7 37
Number of Sells 8 44
Net Activity 6786 -42725
Last 10 Buys Shares
Mara Glickman Aspinall 1,000
Last 10 Sell Shares
Brian Smith 1,000
Stephen S. Tang 1,000
Brian Smith 1,000
Douglas A. Michels 1,000
Douglas A. Michels 1,000
Brian Smith 1,000
Brian Smith 1,000
Charles W. Patrick 1,000
Brian Smith 1,000
Brian Smith 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 22 22 22 22
Low Target Price Estimate 18 18 18 18
Mean Target Price Estimate 19.67 19.67 19.67 19.67
Standard Deviation 2.08 2.08 2.08 2.08
Date of Most Recent Estimate 06/04/18 05/03/18 05/03/18 06/04/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 1
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.67 1.67 1.67 1.75